This $334,788 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate the impact of recent revisions to the Medicare home health payment system (Patient-Driven Groupings Model or PDGM) on access, care delivery, and outcomes for community-living Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The 2-year study, starting September 1, 2023, will leverage Medicare claims, home health assessment, and agency data to:...
This $2,278,636 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to characterize and evaluate different models of nursing home clinician care, predominantly nurse practitioners and physicians, that provide care to nursing home residents with Alzheimer's disease and related dementias (ADRD). The 3-year project will survey a nationally representative sample of nursing home clinicians to understand their practice characteristics, care processes, and...
This $2,497,615 federal Project Grant award, funded by the National Institute on Aging under the Aging Research program (CFDA 93.866), aims to evaluate the impact of new Medicare home health agency (HHA) payment policies on healthcare utilization and outcomes for Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The project has three key objectives: 1) characterizing changes in the ADRD beneficiary population eligible for HHA services, 2) evaluating the effect of...
The National Institute on Aging (NIA) awarded a $917,701 Project Grant (CFDA 93.866 - Aging Research) to Brigham & Women's Hospital Inc. The grant, titled "Skipping the Hospital: Acute Hospital Care at Home for People Living with Dementia," will implement and evaluate an acute hospital care at home (AHCAH) pathway specifically for persons with moderate to severe dementia. The key products and services to be delivered under this 5-year grant include: 1) in-home serious illness...
This Project Grant award from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), will support a research study titled "PROJECT GLORY: GOOD LIFE IN MEMORY CARE". The $416,238 award, with a project period from March 2025 to February 2028, aims to contribute to the understanding of how to promote quality of life for residents with Alzheimer's disease and related dementias (ADRD) in nursing homes. The study will gather first-hand...
This National Institute on Aging (NIA) Project Grant award under CFDA 93.866 - Aging Research, totaling $318,416.00, aims to study the impact of hospice care on the well-being of Alzheimer's disease (AD) patients and their family members. The key objectives are: Examining how hospice care affects the cognitive, functional, and pain management outcomes of AD patients, using natural experiments from the opening of new local hospice facilities as an instrumental variable to overcome selection bias....
This Project Grant award, provided by the National Institutes of Health's National Institute on Aging (CFDA 93.866 - Aging Research), supports a study on the impact of Medicare coverage choice on healthcare utilization and intergenerational transfers among Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The $1,846,173 award, spanning from August 2024 to April 2029, aims to investigate whether ADRD patients in Medicare Advantage (MA) plans experience more preventable...
This $3,732,394 five-year Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will fund a cluster randomized trial to evaluate the effectiveness of the Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP) intervention. The study will be conducted by the University of South Florida and will examine its impact on increasing documentation of advance care planning discussions and hospice use among residents with...
The National Institute on Aging awarded a Project Grant (CFDA 93.866 - Aging Research) in the amount of $2,373,964 to Weill Medical College of Cornell University on September 1, 2024. The award will support a multi-year research project examining the use of telehealth services for long-stay nursing home residents with Alzheimer's disease and related dementias (ADRD). The key objectives are to: 1) Conduct qualitative interviews to understand the facilitators, barriers, and decision-making...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $1,588,040 to Wake Forest University Health Sciences to examine the use of home-based medical care (HBMC) and telemedicine among people living with Alzheimer's disease and related dementias (PLWD) in both public (Medicare fee-for-service) and private (Medicare Advantage) plans. The study aims to evaluate the impact of HBMC and telemedicine on outcomes such as treatment for ADRD,...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to Cedars-Sinai Medical Center is for $2,763,221 over approximately 5 years, with a start date of September 1, 2024. The project aims to examine the impact of physician, hospital, and skilled-nursing facility factors related to geriatric care on the number of days spent at home among persons living with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). Specifically, the researchers will investigate how factors such as physician subspecialty certification in geriatrics, interdisciplinary care teams, and facility experience with AD/ADRD populations affect this key patient-centered outcome. The goal is to inform future policies and interventions that could optimize at-home care for individuals with AD/ADRD.